Beats Medical
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
A cross-disease, multi-symptom digital platform (Colbolt©) that requires no additional hardware, provides broad reach across iOS and Android devices, offers a 5-fold increase in data precision compared to traditional methods, and features an embedded digital biomarkers approach.
Description Brand's website · 2026-10-04
Beats Medical partners with leading pharmaceutical companies to improve real-world data and evidence collection, from pre-clinical stages to drug commercialization, by understanding patients’ symptoms through digital solutions. Their cross-disease, multi-symptom platform, Colbolt©, offers smartphone-based assessments and digital therapies for conditions like Parkinson's and Dyspraxia.
Offerings
Core capabilities Brand's website · 2026-10-04
- The Beats Medical Colbolt© platform
- offering smartphone-based digital assessments (mobility
- fine motor
- speech
- QoL/ePROMs) and digital therapies (DTx) for conditions such as Parkinson's and Dyspraxia.
Pricing Brand's website · 2026-10-04
Not specified
Audience
Target industry Brand's website · 2026-10-04
Leading pharmaceutical companies for R&D and commercialization, clinical research organizations, and patients with CNS and rare conditions.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Beats Medical's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Beats Medical across the index.
Claim Beats Medical — free →Page last updated 2026-10-17.